Pandemic spawns global spike in anxiety and depression: review
The Australian-led study finds prevalence correlates with number of cases of COVID-19 and imposition of lockdowns
The COVID-19 pandemic was associated with a dramatic rise in depressive and anxiety disorders, with women and younger people most affected, according to an Australian-led review of data from 2020.
Global prevalence of major depressive disorder rose by 28% and prevalence of anxiety disorders increased by 26% according to the systematic review and meta-analysis of 48 studies published during the 13-month period ending January 2021.
